FDA’s New Rule Allows for Medical Research Without Informed Consent

Created on 2024-01-29T13:05:14-06:00

Return to the Index

This card pertains to a resource available on the internet.

This card can also be read via Gemini.

In an effort to encourage the discovery of more treatment and diagnostic options in the medical field, the U.S. Food and Drug Administration (FDA) has finalized a rule allowing certain clinical trials to operate without obtaining informed consent from participants.
The rule was issued in late December 2023 and went into effect on Jan. 22, 2024.